Secondary metabolites of Schisandra chinensis in homeostasis regulator adaptogen herbal formula for preventive oncology
Автор: Bocharova O.A., Kazeev I.V., Shevchenko V.E., Ionov N.S., Sheichenko O.P., Bocharov E.V., Karpova R.V., Kucheryanu V.G., Lagunin A.A., Filimonov D.A., Kosorukov V.B., Poroikov V.V., Tutelyan V.A., Pyatigorskaya N.V.
Журнал: Cardiometry @cardiometry
Рубрика: Original research
Статья в выпуске: 27, 2023 года.
Бесплатный доступ
The original herbal formula of homeostasis regulator Multiphytoadaptogen (MPhA) for preventive oncology developed by the N.N. Blokhin Center of Oncology containing phytocomponents from Schizandra chinensis has been investigated in vitro, in vivo and in clinical studies. The MPhA multi-target effects are achieved by optimizing the functioning of the nervous, immune and endocrine defense systems that regulate homeostasis under stress. Everything that has been previously studied for MPhA can be considered as preclinical testing, including clinical research, which can be regarded as the pilot studies. This was allowed because MPhA in Russia is registered as a parapharmaceutical agent and therefore standardized according to established requirements. However, due to the high efficiency of MPhA, a detailed study of the chemical composition and standardization of it is required, including the composition of Schisandra chinensis Baill (Schisandraceae) active components, which turned out to be translocated into MPhA as a result of the extraction technology developed. So, for MPhA identification and standardization we detected the secondary metabolites in the herbal formula MPhA as well as in fruits extract of Schisándra chinénsis using high-performance liquid chromatography in combination with mass spectrometry. Chromatography was performed on an ACQUITY UPLC BEH C18 column in a gradient mode. A TSQ Vantage triple quadrupole mass spectrometer with electrospray ionization was used. Lignans Schizandrin and Schizantherin A were identified in the MPhA as well as in Schisándra chinénsis fruits extract obtained by the technology developed. The determined secondary metabolites can be used for standardization and quality testing of the herbal formula MPhA. In addition, we performed in silico analyzes of Schizandrin and Schizantherin A biological activity spectra using computer program PASS (Prediction of Activity Spectra for Substances). Schizandrin and Schizantherin A activities, according the scientific literature and in silico analysis, correspond to the properties studied for MPhA which therefore fits into the concept of a drug - homeostasis regulator adaptogen for preventive oncology.
Herbal formula mpha, schisándra chinénsis, schizandrin and schizantherin a, adaptogen, homeostasis regulator, preventive oncology, standardization, hplc-ms/ms spectroscopy, pass, pharmaexpert, in silico analysis
Короткий адрес: https://sciup.org/148326624
IDR: 148326624 | DOI: 10.18137/cardiometry.2023.27.6374
Список литературы Secondary metabolites of Schisandra chinensis in homeostasis regulator adaptogen herbal formula for preventive oncology
- Panossian, A.; et al. Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress‐ and aging‐related diseases. Medicinal Research Reviews 2021, 41, 630-703.
- Panossian, A., Efferth, T. Network pharmacology of adaptogens in the assessment of their pleiotropic therapeutic activity. Pharmaceuticals 2022, 15, 1051.
- Panossian, A.; Wikman, G. Evidence‐based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress‐protective activity. Curr. Clin. Pharmacol. 2009, 4, 198‐219.
- Panossian, A. Understanding adaptogenic activity: specificity of the pharmacological action of adaptogens and other phytochemicals. Ann. N. Y. Acad. Sci. 2017, 1401, 49‐64.
- Panossian, A.; Wikman, G.; Sarris, J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010; 17:481‐493.
- Panossian, A. Adaptogens in mental and behavioral disorders. Child Adolesc. Psychiatr. Clin. North Am. 2013, 36, 49‐64.
- Shikov, A.N.; Pozharitskaya, O.N.; Makarov, V.G. Aralia elata var. mandshurica (Rupr. & Maxim.) J. Wen: An overview of pharmacological studies. Phytomedicine 2016, 23, 1409-1421.
- Shikov, A.N.; et al. Oplopanax elatus (Nakai) Nakai: chemistry, traditional use and pharmacology. Chin. J. Nat. Med. (Amsterdam, Neth.) 2014, 12, 721-729.
- Gerontakos, S.; et al. Findings of Russian literature on the clinical application of Eleutherococcus senticosus (Rupr. & Maxim.): A narrative review. Journal of Ethnopharmacology 2021, 278, 114274.
- Wiegant, F.A.C.; Limandjaja, G.; de Poot, S.A.H. 23. Plant Adaptogens Activate Cellular Adaptive Mechanisms by Causing Mild Damage. Adaptation Biology and Medicine: Volume 5, 2008, 319.
- Panossian, A.; Wagner, H. Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration. Phytother Res. 2005, 19, 819‐838.
- Wiegant, F.A.; et al. Plant adaptogens increase lifespan and stress resistance in C. elegans. Biogerontology 2009, 10, 27-42.
- Kaur, P.; et al. Immunopotentiating significance of conventionally used plant adaptogens as modulators in biochemical and molecular signalling pathways in cell mediated processes. Biomed. Pharmacother. 2017, 95, 1815‐1829.
- Melnikov, V.N. A quantitative method for estimating the adaptedness in a physiological study. Theor. Biol. Med. Modell. 2019, 16, 1-9.
- Dhabhar, F.S. The short‐term stress response—mother nature’s mechanism for enhancing protection and performance under conditions of threat, challenge, and opportunity. Front. Neuroendocrinol. 2018, 49, 175‐192.
- Bocharova, O.A; et al. Phytoadaptogens in biotherapy of tumors and geriatrics (Part 1). Ross. Bioterapevticheskii Zh. 2020, 19(2), 13-21.
- Bocharova, O.A.; et al. Phytoadaptogens in biotherapy of tumors and geriatrics (Part 2). Ross. Bioterapevticheskii Zh. 2020, 19(3), 12-20.
- Todorova, V.; et al. Plant adaptogens – history and future perspectives. Nutrients. 2021, 13(8), 2861. DOI: 10.3390/nu13082861.
- Panossian, A.; Brendler, T. The Role of Adaptogens in Prophylaxis and Treatment of Viral Respiratory Infections. Pharmaceuticals 2020, 13, 236.
- Panossian, A.; Seo, E.J.; Efferth, T. Novel molecular mechanisms for the adaptogenic effects of herbal extracts on isolated brain cells using systems biology. Phytomedicine 2018, 50, 257-284. DOI: 10.1016/j.phymed.2018.09.204.
- Shin, D.; et al. Effects of Schisandrae Fructus on menopause symptoms in ovariectomized mice. Journal of Korean Medicine 2016, 37, 39-46.
- Bocharova, O.A.; et al. Research of new phytoadaptogens and possibilities of herbal formulas application. Ross. Bioterapevticheskii Zh. 2020, 19, 35.
- Panossian, A.; Wikman, G.; Sarris, J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine 2010, 17, 481-493.
- Shikov, A.N.; et al. Medicinal plants of the Russian Pharmacopoeia; their history and applications. J. Ethnopharmacol. 2014, 154, 481. DOI: 10.1016/j.jep.2014.04.007.
- Bocharova, O.; et al. The first in vitro and in vivo trials of the phytomixture for anticancer treatment. Farmacevtski Vestnik 1997, 48, 414-415.
- Pozharitskaya, M.M.; et al. Modern aspects of the pathogenesis and treatment of oral mucosa leukoplakia. Methodological guide for doctors; SEI HESMC: Moscow, Russia, 2004; p 46
- Bocharova O.A.; Baryshnikov, A.Yu. Phytoadaptogens in oncology; ZooMedVet: Moscow, Russia, 2004, p 138
- Alperina, E.L.; Bocharov, E.V.; Bocharova, O.A. Actual problems of neuroimmunopathology; Genius Media: Moscow, Russia, 2012, p 423.
- Bocharova, O.A.; et al. Computer-Aided Evaluation of Polyvalent Medications’ Pharmacological Potential. Multiphytoadaptogen as a Case Study. Mol. Inf. 2022 41, 2200176.
- Sheychenko, V.I.; et al. Analytical capabilities of the NMR method for determining the components of Phitomix-40. Factory laboratory. Diagnostics of materials. 2006, 72(8), 15-23.
- Sheychenko, O.P.; et al. Possibility of using electronic absorption spectra for standardization of the multicomponent preparation “Phitomix-40”. Problems of Biol. Med. Pharm. Chem. 2007, 5(2), 20-25.
- Sheychenko, O.P.; et al. Investigation of a complex phytoadaptogen by HPLC. Problems of Biol. Med. Pharm. Chemistry 2012, 10, 52-59.
- Kazeev, I.V.; et al. Tandem mass spectrometry for the analysis of ginsenosides in a phytoadaptogenic composition with antitumor properties. Theor Found Chem. Eng. 2021, 55(6), 780-792.
- Kazeev, I.V.; et al. Tandem mass spectrometry in the technology of determining aralosides of phytoadaptogene compositions. Theor Found Chem. Eng. 2020, 54(6), 1242-1246.
- Bocharova, O.A.; et al. A Potential Method for Standardization of Multiphytoadaptogen: Tandem Mass Spectrometry for Analysis of Biologically Active Substances from Rhodiola rosea. Pharm Chem J. Eng. 2022, 56(1), 78-84.
- Bocharova, O.A.; et al. Eleutherosides Definition by Tandem Mass Spectrometry Technology in Assay of Multiphytoadaptogen for Preventive Oncology. Pharm Chem J. Eng. 2022, 56(6), 806-814.
- Kazeev I.V., et al. Secondary metabolites of Oplopanax elatus: possibilities of standardization of a multifitoadaptogen for preventive oncology// Pharm Chem J. 2023. 57(1), 29-36.
- Novikov, V.S.; Gubanov, I.A. Populyarnyj atlas-opredelitel’. Dikorastushchie rasteniya. 5th ed.; Prosveshchenie/Drofa: Moscow, Russia 2008, pp. 65-66. (in Russian)
- Shikov, A.N.; et al. Traditional and current food use of wild plants listed in the Russian Pharmacopoeia. Front. Pharmacol. 2017, 8, 841.
- Makarov, V.G.; et al. Effect of polyphenol preparation Licol on cebtral nervous systeme. Psychopharmacol. Biol. Narcol. 2004. 4, 601-607.
- Shikov, A.N.; et al. Medicinal Plants from the 14th edition of the Russian Pharmacopoeia, recent updates. J. Ethnopharmacol. 2021, 268, 113685.
- Kosman, V.M.; et al. Pharmacokinetics of lignans from Schisandra chinensis. Review on Clinical Pharmacology and Medicinal Therapy 2015, 13, 3-21
- Poroikov, V.V. Computer-aided drug design: From discovery of novel pharmaceutical agents to systems pharmacology. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 2020, 14, 216-227. DOI: 10.1134/S1990750820030117
- Patil, K.R.; et al. Pentacyclic Triterpenoids Inhibit IKKβ Mediated Activation of NF-κB Pathway: In Silico and In Vitro Evidences. PLoS One. 2015, 10, e0125709.
- Gawande, D.Y., Goel, R.K. Pharmacological validation of in-silico guided novel nootropic potential of Achyranthes aspera L. J. Ethnopharmacol. 2015, 175, 324-334. DOI: 10.1016/j.jep.2015.09.025
- Foudah, A.I.; et al. Phytochemical Screening, In Vitro and In Silico Studies of Volatile Compounds from Petroselinum crispum (Mill) Leaves Grown in Saudi Arabia. Molecules. 2022, 27, 934.
- Yeh, Y.C.; et al. Identification of NSP3 (SH2D3C) as a Prognostic Biomarker of Tumor Progression and Immune Evasion for Lung Cancer and Evaluation of Organosulfur Compounds from Allium sativum L. as Therapeutic Candidates. Biomedicines. 2021, 9, 1582.
- Alehaideb, Z.I.; et al. Bursatella leachii Purple Ink Secretion Concentrate Exerts Cytotoxic Properties against Human Hepatocarcinoma Cell Line (HepG2): In Vitro and In Silico Studies. Molecules. 2022, 27, 826.
- Nasrin, S.; et al. Chemical profiles and pharmacological insights of Anisomeles indica Kuntze: An experimental chemico-biological interaction. Biomed. Pharmacother. 2022, 149, 112842.
- Mácsai, L.; et al. Biological Activities of Four Adaptogenic Plant Extracts and Their Active Substances on a Rotifer Model. Evid. Based Complement. Alternat. Med. 2018, 2018.
- Amujuri, D.; et al. Synthesis and biological evaluation of Schizandrin derivatives as potential anti-cancer agents. European Journal of Medicinal Chemistry. 2018, 149, 182-192.
- Yoganathan, S.; et al. Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer. Cells 2021, 10, 458. DOI: 10.3390/cells10020458
- Dileep Kumar, G.; et al. Synthesis and biological evaluation of Schizandrin derivatives as tubulin polymerization inhibitors. Bioorg Med Chem Lett. 2020, 30, 127354.
- Xu, G.; et al. Molecular Mechanism of the Regulatory Effect of Schisandrol A on the Immune Function of Mice Based on a Transcription Factor Regulatory Network. Frontiers in Pharmacology. 2021, 12.
- Lin, X.; et al. Regulation of cell signaling pathways by Schisandrin in different cancers: Opting for “Swiss Army Knife” instead of “Blunderbuss.” Cellular and Molecular Biology. 2021, 67, 25-32.
- Zhu, P.; et al. Schisandra fruits for the management of drug-induced liver injury in China: A review. Phytomedicine. 2019, 59, 152760.
- Xin, Y.; Yang, Y.; Yu, K.; Wang, H. Filtration of Active Components with Antioxidant Activity Based on the Differing Antioxidant Abilities of Schisandrae Sphenantherae Fructus and Schisandrae Chinensis Fructus through UPLC/MS Coupling with Network Pharmacology. Evidence-Based Complementary and Alternative Medicine 2021, 2021, 1-13.
- Wang, Z.; et al. Schisantherin A induces cell apoptosis through ROS/JNK signaling pathway in human gastric cancer cells. Biochemical Pharmacology. 2020, 173, 113673.
- Zhang, L.; et al. Schisantherin A protects against 6-OHDA-induced dopaminergic neuron damage in zebrafish and cytotoxicity in SH-SY5Y cells through the ROS/NO and AKT/GSK3β pathways. Journal of Ethnopharmacology. 2015, 170, 8-15.
- Panossian, A., et al. The adaptogens Rhodiola and Schizandra modify the response to immobilization stress in rabbits by suppressing the increase of phosphorylated stress‐activated protein kinase, nitric oxide and cortisol. Drug Targets Insights. 2007, 2, 39‐54
- Inglis, J.E.; Lin, P.J.; Kerns, S.L. Nutritional interventions for treating cancer‐related fatigue: a qualitative review. Nutr Cancer. 2019, 71, 21‐40.